Suzannah J. Harnor

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines

Christopher R. Coxon, Elizabeth Anscombe, Suzannah J. Harnor et al. · Journal of Medicinal Chemistry · 2016 · 113 citations · Full text

Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein–Protein Interaction

Gianni Chessari, Ian R. Hardcastle, Jong Sook Ahn et al. · Journal of Medicinal Chemistry · 2021 · 52 citations

Human Toxicity Caused by Indole and Indazole Carboxylate Synthetic Cannabinoid Receptor Agonists: From Horizon Scanning to Notification

S. Hill, Michael Dunn, Céline Cano et al. · Clinical Chemistry · 2017 · 29 citations

Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4

Stephanie M. Myers, Duncan C. Miller, Lauren Molyneux et al. · European Journal of Medicinal Chemistry · 2019 · 21 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +8

2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase

Christopher J. Matheson, Christopher R. Coxon, Richard Bayliss et al. · RSC Medicinal Chemistry · 2020 · 18 citations · Full text